Korean clinical practice guidelines for the diagnosis of hereditary hemolytic anemia released in June 2022 included the G6PD enzyme activity tests because individuals with genetic variants of the G6PD gene are mostly asymptomatic throughout their lifetime; however, these patients may develop acute and very severe hemolytic anemia [1,18]. The gene discussed is G6PD; the disease is non-autoimmune hemolytic anemia.